Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme
European Journal of Cancer2019Vol. 118, pp. 156–165
Citations Over TimeTop 12% of 2019 papers
Romain Varnier, Olivia Le Saux, Sylvie Chabaud, Gwenaëlle Garin, Emilie Sohier, Qing Wang, Sandrine Paindavoine, David Pérol, Christian Baudet, Valéry Attignon, Daniel Pissaloux, Pierre-Étienne Heudel, Benoît You, Cécile Leyronnas, Olivier Collard, Olivier Trédan, Nathalie Bonnin, Jérôme Long, Jean-Philippe Jacquin, Philippe A. Cassier, Olfa Derbel, Gilles Freyer, Alain Viari, Jean‐Yves Blay, Isabelle Ray‐Coquard
Related Papers
- → Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer(2021)37 cited
- → Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort.(2020)3 cited
- → Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer(2020)2 cited
- → Lung Cancer and <i>KRAS</i> -Its Molecular Biology/Genetics and Therapeutic Strategy-(2022)
- → 127P RAS, RAF and NF1 oncogenic mutations in KRAS-mutated lung adenocarcinoma(2022)